EP Patent

EP2957550A1 — Pharmaceutical formulations comprising vilanterol

Assigned to Arven Ilac Sanayi ve Ticaret AS · Expires 2015-12-23 · 10y expired

What this patent protects

The present invention relates to a pharmaceutical formulation for inhalation comprising vilanterol as an active agent, a carrier and magnesium stearate in the treatment and prophylaxis of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) as well as…

USPTO Abstract

The present invention relates to a pharmaceutical formulation for inhalation comprising vilanterol as an active agent, a carrier and magnesium stearate in the treatment and prophylaxis of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) as well as to a process for producing this formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2957550A1
Jurisdiction
EP
Classification
—
Expires
2015-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Arven Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.